SC issues notice on plea challenging cancellation of AIIMS INI CET counselling, Doctors call it 'First Victory'
New Delhi: While considering the plea challenging the cancellation of further rounds of INI CET PG medical counselling in the Institutes of National Importance, the Supreme Court today issued notice to the National Medical Commission (NMC) and the INIs including AIIMS, JIPMER, NIMHAS, PGIMER, and SCTIMS.
During the hearing of the case today, Senior Advocate Gopal Sankaranarayanan and Advocate Tanvi Dubey appeared for the petitioners and informed the court about the timeline that got disrupted due to the COVID-19 pandemic. They also pointed out how a total number of 737 out of seats remained vacant after the first two rounds.
Issuing notice in the matter, the top court bench has listed the matter for further hearing on October 14, 2022.
Medical Dialogues had earlier reported that through a recent notice, AIIMS had informed about regarding the further counselling process for INI-CET for admission in MD/MS/DM(06yrs)/M.Ch(06yrs)MDS courses for AIIMS New Delhi & 11 other INIs.
Clarifying that no further round of seat allocation shall be conducted for INI-CET July 2022 session, the notice mentioned, "In continuation of the schedule of online seat allocation and the order of Hon'ble Supreme court of India in Miscellaneous Application No. 1566/2022 in W.P. (C) No. 1329/2021, no further round of seat allocation for INI-CET July-2022 session will be conducted."
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.